Have you ever wondered that what determines your aging rate might not be your genes, not your skincare products, but the invisible, untouchable bacteria living in your gut? On August 25, 2026, Nature Aging published a landmark study from a Chinese research team [1]. By conducting multi-omics analysis on 1,740 Chinese individuals, the researchers found that the gut microbiome can not only predict “biological age,” but that a specific probiotic—Bifidobacterium pseudocatenulatum—can systematically delay aging by secreting a small molecule called 5-aminovaleric acid betaine (5-AVAB).
In simple terms, your gut may harbor a community of “longevity bacteria” that are quietly determining whether you age gracefully or prematurely.
I. The “Factional Struggle” in Your Gut: Which Gang Does Your Intestine Belong To?
Here is a lesser-known fact: everyone’s gut microbiome is not randomly distributed but can be categorized into several fixed “gangs”—academically termed enterotypes. This study found that the human gut is mainly divided into two major factions: the Bacteroides enterotype (ETB) and the Prevotella enterotype (ETP). Not only do these two factions have different “leaders,” but their “modus operandi”also differ vastly. The Bacteroides enterotype excels at synthesizing vitamin B6, following a “health-preserving” route, while the Prevotella enterotype is rich in lipopolysaccharide synthesis pathways, inherently carrying an “inflammatory constitution.”
The problem arises with aging. In individuals with the Prevotella enterotype, the gut ecosystem deteriorates sharply with age—the core genus Prevotella declines by approximately 40%, while harmful bacteria carrying virulence factors and antibiotic resistance genes seize the opportunity to take over. In contrast, the gut microbiome of individuals with the Bacteroides enterotype remains relatively stable throughout the aging process.
In other words, if you are naturally of the Prevotella enterotype, your gut may “age” faster than that of Bacteroides individuals. The researchers also constructed a “microbiological age clock”(MicroAge), which showed a robust correlation with chronological age (R=0.50, mean absolute error MAE=11.98 years). Bifidobacterium pseudocatenulatum was one of the most important “rejuvenating” predictive factors in this clock—the more of this bacterium in the gut, the younger your “microbiological age.”
II. Who Is the True “Longevity Bacterium”?
In the large sample of 1,740 individuals, the researchers systematically screened all gut bacteria that decrease with age. Bifidobacterium pseudocatenulatum stood out—it not only declined significantly with age across all age groups and regions but also showed consistent results in both males and females.
More critically, the abundance of Bifidobacterium pseudocatenulatum was closely correlated with a range of health indicators: the more Bifidobacterium pseudocatenulatum in the gut, the lower the levels of harmful factors (blood glucose, lipids, inflammation) and the higher the levels of beneficial factors (bone density, lung capacity, metabolic function). However, correlation does not equal causation. To prove that this bacterium truly has anti-aging effects, the researchers conducted a “hardcore”experiment.
III. Nine Months of “Bacterial Therapy”: The Comeback of Aged Mice
The researchers administered Bifidobacterium pseudocatenulatum orally to 18-month-old aged mice (equivalent to approximately 60 years in humans) twice weekly for 9 consecutive months.
The results were encouraging:
Motor function: Treated mice stayed on the rotarod significantly longer, with markedly improved balance and coordination.
Cognitive function: In the novel object recognition test, treated mice demonstrated enhanced learning and memory abilities.
Emotional state: In the tail suspension test, treated mice showed significantly reduced “depressive-like behavior”—shorter immobility time.
Moreover, histological analysis revealed that Bifidobacterium pseudocatenulatum treatment systematically suppressed inflammaging across multiple organs. In the intestine, liver, heart, kidney, lung, and spleen, the senescence marker p21 and the inflammatory marker S100A8 were significantly reduced, while the “youthful” epigenetic marker H3K9me3 was restored. An aged mouse, through oral probiotic administration, achieved a comprehensive “comeback” in motor function, cognition, mood, and organ health.
IV. The Hero Behind the Scenes: 5-AVAB
How does the bacterium work? The researchers identified a key molecule: 5-AVAB. 5-AVAB is a metabolite secreted by Bifidobacterium pseudocatenulatum. In the human body, its levels decline significantly with age. More importantly, the clinical correlation profile of 5-AVAB is nearly identical to that of Bifidobacterium pseudocatenulatum—both are associated with lower inflammation, better metabolism, and stronger physiological function.
To verify that 5-AVAB is indeed the “hero behind the scenes,” the researchers directly supplemented aged mice with 5-AVAB. The results strikingly replicated most of the effects of live bacterial therapy: improved motor function, enhanced cognitive performance, and reduced multi-organ inflammation. At the cellular level, 5-AVAB inhibited oxidative stress-induced cellular senescence, reduced senescence-associated β-galactosidase activity, decreased p21 expression, and restored lamin B1 levels.
In other words, Bifidobacterium pseudocatenulatum secretes the small molecule 5-AVAB, which acts like a “messenger” sending “anti-inflammatory and anti-aging” signals throughout the body.
V. What Does This Mean? — Three Caveats
The significance of this study is self-evident: it is the first to provide a complete chain of evidence from population observation to mechanistic validation, revealing the full pathway of “one probiotic → one metabolite → systemic anti-aging.”
However, before sharing this hope, it is worth pausing to acknowledge three thresholds that this study has yet to cross.
First, this is a mouse study. Although human cohort data support the associations, whether Bifidobacterium pseudocatenulatum can similarly delay aging in humans still requires clinical trials for verification. The gap from mice to humans remains substantial.
Second, 5-AVAB is a double-edged sword. Previous studies have shown that while 5-AVAB has many positive effects (anti-inflammatory, promoting insulin secretion, reducing cancer risk), it has also been associated with cardiovascular disease and fatty liver in certain contexts. This study employed “physiological supplementation”—restoring 5-AVAB levels in elderly individuals to those of younger people—rather than supraphysiological dosing. Dose determines toxicity; do not self-supplement blindly.
Third, enterotypes are innate, but bacteria can be cultivated. Whether you are of the Bacteroides or Prevotella enterotype is largely determined by innate factors and long-term diet. However, the abundance of Bifidobacterium pseudocatenulatum can be modulated through diet and probiotic intervention. The study also found that regular walking was associated with slower microbiological aging, while night-shift work accelerated gut microbiome aging. Eating well, exercising regularly, and getting good sleep—these clichés may be among the most simple and effective ways to nurture your “longevity bacteria.”
Final Thoughts
Perhaps the greatest revelation of this study is that aging does not begin with the wrinkles on your face, but with the “defection” of the bacteria in your gut. While you are anxious about the fine lines at the corners of your eyes, the Bifidobacterium pseudocatenulatum in your gut may be quietly retreating, and the vacancies they leave behind are being occupied by a group of “troublemaking” harmful bacteria.
The good news is that these “longevity bacteria” can be nurtured. Perhaps one day in the future, the anti-aging prescription your doctor gives you will not be expensive creams or injections, but a small sachet of probiotics—letting your gut do the “reverse aging” for you.
References:
[1] Lu, X., Ping, J., Han, Z. et al. A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan. Nat Aging (2026).